Neil Kumar

Affiliations

  • Chief Executive Officer at Bridgebio Pharma Inc. (BBIO), 2025-03-27
  • Director at Lianbio (LIAN), 2021-11-09
  • Chief Executive Officer at Eidos Therapeutics Inc. (EIDX), 2019-07-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EIDX $29.90 882,353 Large Shareholder, Officer, Director 24,575,501 2019-07-03 Filing
EIDX $25.93 1,103,848 Large Shareholder, Officer, Director 23,693,148 2019-05-24 Filing
EIDX $13.96 2,664 Large Shareholder, Officer, Director 22,589,300 2018-12-10 Filing
EIDX $13.29 37,989 Large Shareholder, Officer, Director 22,586,636 2018-12-10 Filing
EIDX $14.36 4,860 Large Shareholder, Officer, Director 22,548,647 2018-12-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BBIO $36.87 75,000 4,948,447 2025-03-25 Filing
BBIO $33.79 37,101 5,023,447 2025-02-25 Filing
BBIO $33.36 37,899 5,060,548 2025-02-25 Filing
BBIO $36.56 76 211,718 2025-02-19 Filing
BBIO $36.14 31,467 211,794 2025-02-19 Filing